1. Home
  2. APYX vs CTSO Comparison

APYX vs CTSO Comparison

Compare APYX & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APYX
  • CTSO
  • Stock Information
  • Founded
  • APYX 1982
  • CTSO 1997
  • Country
  • APYX United States
  • CTSO United States
  • Employees
  • APYX N/A
  • CTSO N/A
  • Industry
  • APYX Medical/Dental Instruments
  • CTSO Medical/Dental Instruments
  • Sector
  • APYX Health Care
  • CTSO Health Care
  • Exchange
  • APYX Nasdaq
  • CTSO Nasdaq
  • Market Cap
  • APYX 61.7M
  • CTSO 51.6M
  • IPO Year
  • APYX 1987
  • CTSO N/A
  • Fundamental
  • Price
  • APYX $1.51
  • CTSO $1.15
  • Analyst Decision
  • APYX Hold
  • CTSO Strong Buy
  • Analyst Count
  • APYX 2
  • CTSO 3
  • Target Price
  • APYX N/A
  • CTSO $4.67
  • AVG Volume (30 Days)
  • APYX 16.8K
  • CTSO 147.4K
  • Earning Date
  • APYX 03-20-2025
  • CTSO 03-06-2025
  • Dividend Yield
  • APYX N/A
  • CTSO N/A
  • EPS Growth
  • APYX N/A
  • CTSO N/A
  • EPS
  • APYX N/A
  • CTSO N/A
  • Revenue
  • APYX $48,542,000.00
  • CTSO $37,739,531.00
  • Revenue This Year
  • APYX N/A
  • CTSO $9.20
  • Revenue Next Year
  • APYX $2.50
  • CTSO $11.64
  • P/E Ratio
  • APYX N/A
  • CTSO N/A
  • Revenue Growth
  • APYX N/A
  • CTSO 1.80
  • 52 Week Low
  • APYX $0.97
  • CTSO $0.70
  • 52 Week High
  • APYX $2.30
  • CTSO $1.61
  • Technical
  • Relative Strength Index (RSI)
  • APYX 53.42
  • CTSO 55.74
  • Support Level
  • APYX $1.42
  • CTSO $1.06
  • Resistance Level
  • APYX $1.56
  • CTSO $1.61
  • Average True Range (ATR)
  • APYX 0.08
  • CTSO 0.13
  • MACD
  • APYX 0.01
  • CTSO 0.01
  • Stochastic Oscillator
  • APYX 81.41
  • CTSO 29.34

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: